{
    "xml": "<topic id=\"PHP78972\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/zoladex-la\" basename=\"zoladex-la\" title=\"Zoladex LA\">\n<title>Zoladex LA<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP79597\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/clinical-medicinal-product-information/zoladex-la\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Locally advanced prostate cancer as an alternative to surgical castration</p>\n<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer</p>\n<p outputclass=\"therapeuticIndication\">Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer</p>\n<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10.8&#8239;mg every 12&#8239;weeks, to be administered into the anterior abdominal wall.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP78972",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/zoladex-la",
    "basename": "zoladex-la",
    "title": "Zoladex LA",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Locally advanced prostate cancer as an alternative to surgical castration",
                        "html": "Locally advanced prostate cancer as an alternative to surgical castration"
                    },
                    {
                        "textContent": "Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer",
                        "html": "Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer"
                    },
                    {
                        "textContent": "Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer",
                        "html": "Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer"
                    },
                    {
                        "textContent": "Metastatic prostate cancer",
                        "html": "Metastatic prostate cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "10.8 mg every 12 weeks, to be administered into the anterior abdominal wall.",
                        "html": "<p>10.8&#8239;mg every 12&#8239;weeks, to be administered into the anterior abdominal wall.</p>"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}